Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

This publication has 23 references indexed in Scilit:

• Second-line treatment with ifosfamide and carboplatin in patients with ovarian carcinoma relapsing after treatment with carboplatin
  European Journal Of Cancer, 1994
• Second‐line chemotherapy for recurrent carcinoma of the ovary
  Cancer, 1993
• A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion
  Anti-Cancer Drugs, 1993
• Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
  Journal of Clinical Oncology, 1992
• Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.
  Journal of Clinical Oncology, 1992
• Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group study
  European Journal of Cancer and Clinical Oncology, 1991
• The disposition of carboplatin in ovarian cancer patients
  Cancer Chemotherapy and Pharmacology, 1988
• RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA
  The Lancet, 1984
• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
  Cancer Chemotherapy and Pharmacology, 1982
• Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
  Biochemical Medicine, 1977